| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |